ST
CLVS

Spot Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Spot Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-26,500
Closed -$364K – 3654
2016
Q2 		$364K Sell
26,500
-55,900
-68% -$817K 0.01% 1830
2016
Q1 		$1.58M Buy
+82,400
New +$1.74M 0.03% 825
2015
Q4 		– Sell
-1,000
Closed -$92K – 4198
2015
Q3 		$92K Buy
1,000
+400
+67% +$34.6K ﹤0.01% 3086
2015
Q2 		$53K Sell
600
-3,900
-87% -$334K ﹤0.01% 3267
2015
Q1 		$334K Sell
4,500
-500
-10% -$35.3K ﹤0.01% 2410
2014
Q4 		$280K Sell
5,000
-10,800
-68% -$568K ﹤0.01% 2721
2014
Q3 		$717K Sell
15,800
-19,200
-55% -$802K ﹤0.01% 2317
2014
Q2 		$1.45M Buy
+35,000
New +$1.8M 0.01% 1872

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's CLVS Position: Q2 2016 in Review

Spot Trading sold out of Clovis Oncology, Inc. (CLVS) in Q2 2016, closing a stake of 6,426 shares — an estimated $93.9K sold.

Spot Trading first reported a position in CLVS in Q3 2013 and held it in 6 quarters. The position peaked at $333K in Q3 2013. 122 funds tracked by Wall St. Rank hold CLVS as of Q2 2016.

  • Spot Trading reported no remaining Clovis Oncology, Inc. position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 6,426 Clovis Oncology, Inc. shares in Q2 2016, an estimated $93.9K.
  • Spot Trading first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 6 quarters.
  • Spot Trading's Clovis Oncology, Inc. position peaked at $333K in Q3 2013.
  • 122 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.